Central Pacific Bank Trust Division Raises Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Central Pacific Bank Trust Division boosted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 77.8% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 8,000 shares of the pharmacy operator’s stock after acquiring an additional 3,500 shares during the quarter. Central Pacific Bank Trust Division’s holdings in Walgreens Boots Alliance were worth $72,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Capital World Investors lifted its position in Walgreens Boots Alliance by 57.5% during the first quarter. Capital World Investors now owns 29,061,021 shares of the pharmacy operator’s stock valued at $630,334,000 after purchasing an additional 10,612,373 shares during the period. Thompson Siegel & Walmsley LLC lifted its holdings in shares of Walgreens Boots Alliance by 98.8% in the 2nd quarter. Thompson Siegel & Walmsley LLC now owns 6,021,126 shares of the pharmacy operator’s stock valued at $72,826,000 after buying an additional 2,992,648 shares during the period. Newport Trust Company LLC purchased a new stake in shares of Walgreens Boots Alliance in the second quarter worth about $31,028,000. Swedbank AB acquired a new stake in Walgreens Boots Alliance during the first quarter worth about $16,365,000. Finally, Minneapolis Portfolio Management Group LLC purchased a new position in Walgreens Boots Alliance during the first quarter valued at approximately $13,710,000. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA traded up $0.05 during midday trading on Friday, hitting $8.72. The company had a trading volume of 16,142,068 shares, compared to its average volume of 16,421,242. Walgreens Boots Alliance, Inc. has a twelve month low of $8.22 and a twelve month high of $27.05. The stock has a market cap of $7.53 billion, a price-to-earnings ratio of -1.29, a price-to-earnings-growth ratio of 0.99 and a beta of 0.70. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31. The business’s 50-day simple moving average is $9.73 and its 200-day simple moving average is $13.91.

Walgreens Boots Alliance Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Wednesday, August 21st were issued a $0.25 dividend. The ex-dividend date was Wednesday, August 21st. This represents a $1.00 annualized dividend and a yield of 11.47%. Walgreens Boots Alliance’s payout ratio is -14.84%.

Analysts Set New Price Targets

WBA has been the topic of several recent research reports. JPMorgan Chase & Co. lowered their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Evercore ISI dropped their price target on shares of Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a research report on Friday, June 28th. Barclays decreased their price objective on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating for the company in a research report on Tuesday, July 23rd. UBS Group dropped their target price on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 3rd. Finally, Morgan Stanley cut their price target on Walgreens Boots Alliance from $13.00 to $9.00 and set an “underweight” rating for the company in a research note on Friday, June 28th. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the company. According to MarketBeat.com, Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average target price of $14.73.

View Our Latest Research Report on WBA

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.